TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,447
|
1,517
|
1,512 |
| Financial expenses |
18
|
6
|
0 |
| Earnings before taxes |
13
|
90
|
76 |
| EBITDA |
54
|
117
|
110 |
| Total assets |
884
|
1,047
|
696 |
| Current assets |
666
|
872
|
555 |
| Current liabilities |
524
|
701
|
400 |
| Equity capital |
337
|
326
|
280 |
| - share capital |
18
|
18
|
20 |
| Employees (average) |
6
|
8
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
38.1%
|
31.1%
|
40.2% |
| Turnover per employee |
241
|
190
|
302 |
| Profit as a percentage of turnover |
0.9%
|
5.9%
|
5.0% |
| Return on assets (ROA) |
3.5%
|
9.2%
|
10.9% |
| Current ratio |
127.1%
|
124.4%
|
138.8% |
| Return on equity (ROE) |
3.9%
|
27.6%
|
27.1% |
| Change turnover |
-74
|
128
|
30 |
| Change turnover % |
-5%
|
9%
|
2% |
| Chg. No. of employees |
-2
|
3
|
0 |
| Chg. No. of employees % |
-25%
|
60%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.